Candel Therapeutics, Inc. (CADL)
NASDAQ: CADL · Real-Time Price · USD
5.79
-0.03 (-0.52%)
At close: Aug 29, 2025, 4:00 PM
5.78
-0.01 (-0.17%)
After-hours: Aug 29, 2025, 7:05 PM EDT
Candel Therapeutics Market Cap
Candel Therapeutics has a market cap or net worth of $317.84 million as of August 29, 2025. Its market cap has increased by 88.33% in one year.
Market Cap
317.84M
Enterprise Value
225.50M
1-Year Change
88.33%
Ranking
Category
Stock Price
$5.79
Market Cap Chart
Since the IPO on July 27, 2021, Candel Therapeutics's market cap has increased from $222.39M to $317.84M, an increase of 42.92%. That is a compound annual growth rate of 9.12%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 317.84M | -13.79% |
| Dec 31, 2024 | 368.69M | 767.25% |
| Dec 29, 2023 | 42.51M | -17.80% |
| Dec 30, 2022 | 51.72M | -76.95% |
| Dec 31, 2021 | 224.35M | 0.88% |
| Jul 27, 2021 | 222.39M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.11B |
| Johnson & Johnson | 422.54B |
| AbbVie | 367.30B |
| UnitedHealth Group | 273.78B |
| Novo Nordisk | 249.15B |
| AstraZeneca | 247.41B |
| Novartis AG | 245.07B |
| Abbott Laboratories | 228.64B |